Radiation protection issues in proton therapy

Similar documents
Radiation Shielding of a 230 MeV Proton Cyclotron For Cancer Therapy

8/3/2016. Chia-Ho, Hua St. Jude Children's Research Hospital. Kevin Teo The Hospital of the University of Pennsylvania

Outline. Physics of Charge Particle Motion. Physics of Charge Particle Motion 7/31/2014. Proton Therapy I: Basic Proton Therapy

Secondary Neutron Dose Measurement for Proton Line Scanning Therapy

Towards efficient and accurate particle transport simulation in medical applications

Overview and Status of the Austrian Particle Therapy Facility MedAustron. Peter Urschütz

Development of beam delivery systems for proton (ion) therapy

COMPARISON OF COMPUTER CODES APPLICABILITY IN SHIELDING DESIGN FOR HADRON THERAPY FACILITIES *

THE mono-energetic hadron beam such as heavy-ions or

arxiv: v2 [physics.med-ph] 29 May 2015

Prompt gamma measurements for the verification of dose deposition in proton therapy. Contents. Two Proton Beam Facilities for Therapy and Research

Neutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators

Progress in Nuclear Science and Technology, Volume 6,

NEUTRON H*(10) INSIDE A PROTON THERAPY FACILITY: COMPARISON BETWEEN MONTE CARLO SIMULATIONS AND WENDI-2 MEASUREMENTS

Monte Carlo simulations of stray neutron radiation exposures in proton therapy

Estimate of Photonuclear Reaction in a Medical Linear Accelerator Using a Water-Equivalent Phantom

Physics of particles. H. Paganetti PhD Massachusetts General Hospital & Harvard Medical School

Volume 1 No. 4, October 2011 ISSN International Journal of Science and Technology IJST Journal. All rights reserved

Optimization of hadron therapy proton beam using Monte Carlo code on GPU

Beam Optics for a Scanned Proton Beam at Loma Linda University Medical Center

Radiation safety of the Danish Center for Proton Therapy (DCPT) Lars Hjorth Præstegaard Dept. of Medical Physics, Aarhus University Hospital

Physics of Novel Radiation Modalities Particles and Isotopes. Todd Pawlicki, Ph.D. UC San Diego

Monte Carlo Simulation concerning Particle Therapy

Shielding verification and neutron dose evaluation of the Mevion S250 proton therapy unit

Radiation Shielding. PTCOG 57 Cincinnati, USA (2018)

Secondary Particles Produced by Hadron Therapy

MONTE CARLO SIMULATION FOR EVALUATION OF DOSE DISTRIBUTION IN PROTON THERAPY *

Basic Radiation Physics of Protons

Estimating proton beam energy spread using Bragg peak measurement

Calculations of Photoneutrons from Varian Clinac Accelerators and Their Transmissions in Materials*

Laser-Accelerated protons for radiation therapy

Neutron Spectroscopy in Proton Therapy

Dielectric Wall Accelerator (DWA) and Distal Edge Tracking Proton Delivery System Rock Mackie Professor Dept of Medical Physics UW Madison Co-Founder

Radiation damage calculation in PHITS

Secondary Radiation and Shielding Design for Particle Therapy Facilities

ACCELERATORS AND MEDICAL PHYSICS 3

Shielding Design Considerations for Proton Therapy Facilities

Magnetic removal of electron contamination in radiotherapy x-ray beams

Quality-Assurance Check of Collimator and Phantom- Scatter Factors

assuming continuous slowing down approximation , full width at half maximum (FWHM), W 80 20

A study on the cost of concrete shielding in a standard radiotherapy facility room

Particle Beam Technology and Delivery

Monte Carlo study of the potential reduction in out-of-field dose using a patient-specific aperture in pencil beam scanning proton therapy

Shielding design for a laser-accelerated proton therapy system

A Monte Carlo Study of the Relationship between the Time. Structures of Prompt Gammas and in vivo Radiation Dose in.

CHARACTERISTICS OF DEGRADED ELECTRON BEAMS PRODUCED BY NOVAC7 IORT ACCELERATOR

Radiation Protection Dosimetry (2007), Vol. 126, No. 1 4, pp Advance Access publication 11 May 2007

Accelerators for Hadrontherapy -- Present & Future --

Squeezing the proton. towards small proton therapy systems. Roelf Slopsema. M.Sc. / UF Health Proton Therapy Institute

Heuijin Lim, Manwoo Lee, Jungyu Yi, Sang Koo Kang, Me Young Kim, Dong Hyeok Jeong

Today, I will present the first of two lectures on neutron interactions.

Measurement of induced radioactivity in air and water for medical accelerators

Modelling of a proton spot scanning system using MCNP6

The Radiological Physics Center s standard dataset for small field size output factors

Monte Carlo Analyses of X-Ray Absorption, Noise, and Detective Quantum Efficiency Considering Therapeutic X-Ray Spectrum in Portal Imaging Detector

Interactions of Particulate Radiation with Matter. Purpose. Importance of particulate interactions

Low energy linear acceleratordriven subcritical assembly

A Measuring System with Recombination Chamber for Photoneutron Dosimetry at Medical Linear Accelerators

Monte Carlo simulation of the photoneutron field in linac radiotherapy treatments with different collimation systems

Secondary neutron dose measurement for proton eye treatment using an eye snout with a borated neutron absorber

Neutron Fluence and Energy Spectra Around the Varian Clinac 2lOOC/23OOC Medical Accelerator

Best Particle Therapy, Inc. is Developing a Highly Revolutionary New Treatment for Cancer Therapy

Fitting the Bragg peak for accurate proton range determination

I. INTRODUCTION EXPERIMENTAL

Michael Dunn Nuclear Data Group Leader Nuclear Science & Technology Division Medical Physics Working Group Meeting October 26, 2005

FLUKA simulations of selected topics regarding proton pencil beam scanning

Peter J. Biggs Ph.D. Massachusetts General Hospital Harvard Medical School Boston, MA 02114

The Influence of Brass Compensator Thickness and Field Size on Neutron Contamination Spectrum in 18MV Elekta SL 75/25 Medical Linear Accelerator

Activation Products in Proton Therapy

Cyclotrons for Particle Therapy

Latest developments in PET verification of proton therapy

IRPA 2 nd European Congress, Paris, May Session: RP in Medicine - Workers. Activation Products In Medical Linear Accelerators

Hadron Therapy Medical Applications

Measurement of secondary particle production induced by particle therapy ion beams impinging on a PMMA target

Medical Applications of Particle Accelerators

Radiation Safety. PIXE PAN 2008 Ed Stech University of Notre Dame

Since the beam from the JNC linac is a very high current, low energy beam, energy loss induced in the material irradiated by the beam becomes very lar

THE UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER GRADUATE COLLEGE MONTE CARLO SIMULATION FOR THE MEVION S250 PROTON THERAPY SYSTEM: A TOPAS STUDY

ASSESSING LEAKAGE WORKLOADS OF MEDICAL LINEAR ACCELERATORS FOR IMRT AND TBI TECHNIQUES

Shielding Design for the Imaging and Medical Beamline at the Australian Synchrotron

arxiv: v1 [physics.ins-det] 26 Jan 2016

Journal of Radiation Protection and Research

New irradiation zones at the CERN-PS

Physics of Particle Beams. Hsiao-Ming Lu, Ph.D., Jay Flanz, Ph.D., Harald Paganetti, Ph.D. Massachusetts General Hospital Harvard Medical School

MAGNETIC FIELD EFFECTS ON THE NANOSCOPIC CLUSTER-SIZE DISTRIBUTION FOR THERAPEUTIC PROTON BEAMS

Units S H I E L D I N H = D Q. H: Dose equivalent (Sv) D: Dose (Gy) Q: Quality Factor. 1Sv = 1 J/Kg. 1Gy = 1 J/Kg

Simulation of light ion transport in a water phantom using Geant4.

The scanning microbeam PIXE analysis facility at NIRS

The volume effect of detectors in the dosimetry of small fields used in IMRT

Comparative Analysis of Nuclear Cross Sections in Monte Carlo Methods for Medical Physics Applications

Electron therapy Class 2: Review questions

ESTIMATION OF 90 SCATTERING COEFFICIENT IN THE SHIELDING CALCULATION OF DIAGNOSTIC X-RAY EQUIPMENT

Energy response for high-energy neutrons of multi-functional electronic personal dosemeter

Markus Roth TU Darmstadt

The heavy ion irradiation facility at KVI-CART

NEUTRON SPECTROMETRY WITH BUBBLE DETECTORS

Recent Activities on Neutron Calibration Fields at FRS of JAERI

Using Prompt gamma ray emission to address uncertainties in proton therapy

INTRODUCTION TO IONIZING RADIATION (Attix Chapter 1 p. 1-5)

Neutron field analysis for a proton therapy installation

Transcription:

Protons IMRT Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland

Overview of presentation 1. Proton therapy: An overview 2. Radiation protection issues: Staff 3. Radiation protection issues: The patient 4. Summary

Dose (arbitrary units) Proton therapy: An overview Depth dose curves for photons (15MV) and protons (177MeV) 3 2 1 0 0 5 10 15 20 25 Depth in water (cm) Dose concentrated in small volume in Bragg peak.

Proton therapy: An overview The Spread-Out-Bragg-Peak target

Proton therapy: An overview Passive scattering in practice Range-shifter wheel Scatterer Collimator Compensator Target Patient

Proton therapy: An overview Active scanning Magnetic scanner Proton pencil beam Target Range shifter plate Patient

Proton therapy: An overview Example actively scanned proton treatments Meningioma (3 fields) Sacral chordoma (2 fields)

Overview of presentation 1. Proton therapy: An overview 2. Radiation protection issues: Staff 3. Radiation protection issues: The patient 4. Summary

Radiation protection issues: Staff A typical proton therapy facility (e.g. PSI) Energy degrader To vary energy, the Multiple wedges move extracted in beam must be and out of beam to vary degraded after extraction amount of degrading (Energy Selection material seen by beam System) Scatters beam, which must be then sharpened by collimators and slits Inefficient and lossy, but fast. 250 MeV proton Cyclotron A fixed energy accelerator

Radiation protection issues: Staff G1 G2 Gantries (G1/G2) Rotating beam lines 70-250 MeV beam Max range ~32 cm Active scanning Eye irradiations G1-15-20 patients a day Horizontal fixed beam line G2 in service from end 70 MeV 2012 beam Maximum range 3.5cm Passive scattering delivery 4-8 patients a day A typical proton therapy facility (e.g. PSI)

Radiation protection issues: Staff Radiation protection issues for proton therapy Even the highest energy protons (250MeV) stop in a few centimeters of concrete So the main concern from the radiation protection point of view are not protons but secondary particles, in particular neutrons.

Radiation protection issues: Staff ~1%/cm of primary protons are lost due to interactions with atomic nuclei, which then produce secondary particles. E.g. Neutrons (p,xn) Secondary protons (p,xp ) Primary protons

Radiation protection issues: Staff Secondary particle production by protons E.g. MCNPX Monte Carlo calculations for a passive scattering nozzle (Hitachi, Houston) p and p flux n flux Fontenot et al, Phys. Med. Biol. 53 (2008) 1677 1688

Radiation protection issues: Staff The PSI proton therapy facility and it s major neutron sources OPTIS2 (Passive) Gantry 2 (scanning) Gantry 1 (scanning) Major sources of neutrons

Radiation protection issues: Staff Analytically calculated equivalent dose rates (μsv/h) 0.3 OPTIS2 (Passive) 0.05 2.0 1-2 Gantry 2 (scanning) 0.13 Gantry 1 (scanning) Major sources of neutrons 0.02 0.03 Teichmann 2004, Internal PSI report

Radiation protection issues: Staff Shielding for proton therapy facilities Based on analytical calculations (confirmed by measurements) dose rates in entrances, control rooms and public areas can be reduced below legal limits For the PSI facility, to reduce extraneous neutron dose minimum of 2-4 meters of concrete is required For a single treatment room, concrete costs alone can be of the order of 500000 pounds or more

Radiation protection issues: Staff How accurate are analytical calculations? Monte Carlo Analytical Position Hm (MCPNX) Hc Hc/Hm Hc Hc/Hm A 7.0x10-10 1.1x10-8 15 2.8x10-10 0.4 B 2.6x10-8 1.0x10-7 4 3.0x10-8 1.2 C 4.1x10-10 2.6x10-8 63 1.0x10-9 2.4 Analytical calculations can be up to two orders of magnitude too conservative. MC calculations seem to be more accurate (within a factor 2) but more difficult. Consequences for shielding costs? Newhauser et al 2002, Nucl. Inst. Meth. Phys. Res. 476, 80-84

Overview of presentation 1. Proton therapy: An overview 2. Radiation protection issues: Staff 3. Radiation protection issues: The patient 4. Summary

Irradiated volume Neutron equivalent dose (H/mSv/Treatment Gy) Absorbed dose (D/mGy/Treatment Gy) Radiation protection issues: The patient Neutron and photon scatter doses for protons and photons 10 3 10 2 10 1 10 0 10-1 10-2 10 3 10 2 10 1 10 0 10-1 10-2 Neutron dose (16MV photons) Neutron dose (passive) Neutron dose (scanning) Scatter dose (Siemens) Scatter dose (Varian) 10-3 0 20 40 60 80 Distance from target (cm) 10-3 Adapted from Haelg et al 2012, Submitted to Medical Physics

Radiation protection issues: The patient but don t forget the primary dose IMRT A comparison of non-target integral doses for IMRT and scanned protons for nine pediatric cases Protons On average, protons reduced integral dose by a factor 2

Radiation protection issues: The patient Are there potential cost consequences from reducing integral dose?* CEPN ISOE Information sheet No. 34 July 2003 ~100 Euro 0 100 200 300 400 500 600 Alpha value per man-msv (Euro) * With thanks to Hakan Nystrom, Skandion Clinic, Sweden

Radiation protection issues: The patient Are there potential cost consequences from reducing integral dose?* For 74Gy treatment: Effective dose (IMRT) = 54mSv x 74Gy 4000mSv Effective dose (protons) = 4000mSv / 2 2000mSv Alpha value saving = 2000mSv x 100 = 200000 per patient! * With thanks to Hakan Nystrom, Skandion clinic, Sweden

Summary Due to the Bragg peak characteristics of the depth dose curve, proton therapy can deliver highly conformal treatments with significantly reduced integral dose to the patient. Due to the limited range of therapeutic protons (<=32 cm in water), challenges for radiation protection and shielding are mainly to do with secondary neutron production Analytical shielding calculations are relatively straightforward but tend to overestimate transmitted dose rates. MC calculations are more accurate. Consequences for shielding costs? The significantly reduced integral dose of protons may have important radiation protection (and cost? ) consequences for the patient, particularly pediatrics.

Thank you! P +